Page 1690 - Clinical Small Animal Internal Medicine

1628 Index

pneumothorax (cont’d) salmon poisoning disease 914 acute respiratory failure 385–386,
VetBooks.ir point‐of‐care (POC) tests 316, tetanus 968–969 complications 401
surgical approaches to thoracic
spotted fever and typhus group
388–389, 398
disease 326–327, 330
Rickettsia 939
fluid therapy 364
417, 947 tularemia 957 head trauma 756
point of maximum intensity viral infections 844 respiratory pattern‐based approach
(PMI) 124 Wolbachia pipientis infection 918 to dyspnea 292
point source epidemic curves polyphagia 94 settings 396
834, 835 polyps 616–617, 616 surgical approaches to thoracic
poisoning see acute poisoning polyunsaturated fatty acids (PUFA) disease 326
polioencephalomyelopathy (PEM) 782 atopic dermatitis 1409–1410 positive inotropes
polycythemia 1214–1215 chronic kidney disease 1169, 1172 heart failure 187, 189–190, 194,
polycythemia vera (PV) 1228 cutaneous manifestations of systemic 195, 196
polymerase chain reaction for antigen disease 1487 septic shock 427
receptor rearrangement feline bronchial asthma 303 shock 410
(PARR) 633, 1232 miscellaneous skin diseases 1497, positive pressure ventilation
polymerase 1503, 1505 (PPV) 320
chain reaction (PCR/RT‐PCR) osteoarthritis 1535 positron emission tomography
actinomycosis 978 polyuria and polydipsia (PU/PD) (PET) 1210
acute kidney injury 1093 65–68 postclipping hair follicle arrest
bacterial infections 845 diabetes mellitus 94, 96 1436–1437, 1437
bartonellosis 920, 923 diagnosis 66–68 postoperative ileus 570–571
canine brucellosis 964 etiology/pathophysiology postural reactions 732–733, 818
canine infectious respiratory disease 65–66, 66 see also gait and posture
complex 1036 first‐tier diagnostic tests 66–67 potassium citrate
canine influenza virus 866 gastritis and gastric ulceration 551 supplementation 1138
canine parvovirus type 2 859 history and clinical signs 66 potassium homeostasis and disorders
ehrlichiosis and anaplasmosis hypoadrenocorticism 67, 86, 88 acute kidney injury 1096–1098
910–911 liver disease 645 acute respiratory failure 382
feline coronavirus 874–875 physiology of water metabolism 65 chronic kidney disease 1171
feline immunodeficiency virus 884 portosystemic shunts and dialysis 1177–1178
feline inflammatory liver microvascular dysplasia 714 feline inflammatory liver
disease 690 rectoanal diseases 609 disease 690
feline leukemia virus 877, second‐tier diagnostic tests 67 glomerular disease 1104–1105
879–880 signalment 66 hyperkalemia 85, 88, 209, 210,
feline viral upper respiratory tract treatment 68, 68 1096–1098, 1104–1105,
disease 888 water deprivation test 67–68 1109–1112, 1112, 1177–1178
fungal infections 847 POMC see proopiomelanocortin hypoadrenocorticism 85, 88, 90
hemotropic Mycoplasma 928 portal hypertension (PH) hypokalemia 90, 382, 690, 1171
leptospirosis 947 cirrhosis 705, 711 supraventricular arrhythmias
Lyme borreliosis 941–942 hepatobiliary disease 672–673 209, 210
meningoencephalitis and pathophysiology 643 urethral obstruction 1109–1112,
meningomyelitis 799 portosystemic shunts and 1112
nonhemotropic Mycoplasma, microvascular dysplasia 715 potassium magnesium pyrophosphate
Ureaplasma, and L‐form portal thrombosis 673 urolithiasis 1132
bacteria 934 portal venous hypoplasia/microvascular potentiated sulfonamides
papillomaviruses 863 dysplasia (PVH‐MVD) 713, 1046–1047
protozoal and arthropod‐borne 715–717 power 10, 24
infections 843 portosystemic shunts see acquired PPDH see peritoneopericardial
protozoal and protozoa‐like portosystemic shunts; congenital diaphragmatic hernia
infections 1004, 1006, 1011, portosystemic shunts PPE see personal protective equipment
1014–1015, 1017, 1019–1020 portosystemic vascular anomalies PPI see proton pump inhibitors
Q fever 960 (PSVA) 103, 105 PPV see positive pressure ventilation
rabies 894 positive end‐expiratory pressure (PEEP) PRA see plasma renin activity